PMC Medical Group, LLC

PMC Medical Group, LLC was paid $11.16M by Medicaid between Jan 2018 and Dec 2024, across 37 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 40% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	42,922	$1.63M
2019	55,713	$2.24M
2020	51,056	$1.97M
2021	45,094	$1.91M
2022	40,518	$1.71M
2023	27,581	$1.10M
2024incomplete	14,564	$597K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	40%	111,531	79,199	$4.51M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	34%	80,819	54,900	$3.74M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	14%	46,222	33,259	$1.52M
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	8.7%	20,709	13,875	$970K
90837	Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient	1.3%	2,458	1,042	$142K
90832	Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient	<1%	4,789	3,243	$100K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	2,569	1,786	$68K
99215	Doctor's office visit, returning patient (complex)Prolong outpt/office vis	<1%	516	423	$24K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	1,256	1,170	$15K
96127		<1%	2,302	1,895	$8K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	125	124	$8K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	1,318	1,158	$7K

25 more codes

99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	141	$7K
H0015	Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education	<1%	67	$7K
90834	Psychotherapy session, about 45 minutes	<1%	163	$7K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	324	$5K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	317	$4K
90791	Psychiatric diagnostic evaluation	<1%	49	$3K
99442		<1%	479	$3K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	24	$1K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	29	$1K
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	183	$1K
90472	Immunization administration, each additional vaccine (list separately)	<1%	240	$1K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	12	$615.24
99441		<1%	74	$568.64
90688		<1%	21	$409.83
81003		<1%	210	$338.35
96160		<1%	177	$260.68
0072A		<1%	13	$242.00
J1010	Injection, methylprednisolone acetate, 1 mg	<1%	19	$95.14
99173		<1%	20	$61.25
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	46	$59.70
81002		<1%	15	$35.10
90686		<1%	114	$17.03
Q9992	Injection, buprenorphine extended-release (sublocade), greater than 100 mg	0%	66	$0.00
90656		0%	15	$0.00
91307		0%	16	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHOGAN, MATTHEW (PRESIDENT)

Parent organizationCURAM, LLC